How Investors May Respond To Gap (GAP) Doubling Profit, Raising Guidance And Changing Old Navy Leadership

• In late August 2026, The Gap, Inc. reported second-quarter results showing slightly lower sales of US$3,651 million but a more than doubled net income of US$501 million, raised full-year earnings guidance to diluted EPS of about US$3.77–US$3.87, and confirmed third-quarter net sales guidance of 1.5%–2.5% year-over-year growth.
• The company also completed a sizable share repurchase program and installed a new Old Navy CEO after the brand’s first negative comparable sales in 12 quarters, underscoring management’s focus on profitability, capital returns, and brand stewardship even as Old Navy’s latest quarter underlined execution challenges.
• Next, we’ll examine how Gap’s upgraded earnings outlook alters the earlier investment narrative around margin discipline and brand reinvigoration.

AI is about to change healthcare. These 37 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

Gap Investment Narrative Recap

To own Gap today, you have to believe management can sustain stronger profitability while stabilizing revenue across Old Navy, Gap, Banana Republic, and Athleta. The latest results and higher EPS guidance reinforce the margin story, but Old Navy’s negative comps keep brand execution as the key near term catalyst and the biggest risk. The Q2 update does not eliminate those concerns, it simply buys management more credibility and time to show consistent follow through.

The most relevant development here is Gap’s completion of a US$599.22 million buyback, retiring about 6.67% of shares under the March 2026 authorization. For a thesis centered on earnings power and margin discipline, fewer shares magnify per share results when profits are healthy, but they also increase your exposure if brand missteps or tariff and cost pressures reappear. How you view that trade off will likely color how much weight you give to the raised EPS guidance.

Yet behind the stronger EPS outlook, investors should be aware that Old Navy’s first negative comps in 12 quarters could signal...

Read the full narrative on Gap (it's free!)

Gap's narrative projects $16.4 billion revenue and $1.0 billion earnings by 2029.

Uncover how Gap's forecasts yield a $26.24 fair value, a 17% upside to its current price.

Exploring Other Perspectives

Before this Q2 surprise, the most optimistic analysts were already baking in revenue of about US$17.3 billion and earnings near US$1.1 billion, but their upbeat view on digital growth and an Athleta resurgence sits in sharp contrast to ongoing worries about store traffic and brand dilution, reminding you that equally informed investors can see the same Gap story very differently.

Explore 6 other fair value estimates on Gap - why the stock might be worth as much as 61% more than the current price!

Form Your Own Verdict

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Gap research is our analysis highlighting 3 key rewards and 3 important warning signs that could impact your investment decision.
• Our free Gap research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Gap's overall financial health at a glance.

Want Some Alternatives?

Our top stock finds are flying under the radar-for now. Get in early:

• Capitalize on the AI infrastructure supercycle with our selection of the 55 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
• Outshine the giants: these 19 early-stage AI stocks could fund your retirement.
• Uncover the next big thing with 22 elite penny stocks that balance risk and reward.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com